CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Getinge Interim Report April-June 2026: Good organic growth, high profitability and strong cash flow

EarningsPositive
AI Analysis

Summary

Getinge reported strong Q2 2026 interim results with good organic growth, high profitability, and strong cash flow, with increases noted in most Acute Care Therapies product categories.

Importance:2/10
Sentiment:
0.70
earningsinterim reportQ2 2026organic growthcash flowAcute Care Therapies

Read the original article

Published by PR Newswire Biotech on July 17, 2026 6:35 AM

Read Original